Treatment-induced immunosuppression in newly diagnosed high-grade gliomas: A NABTT CNS consortium study

被引：0
|
作者：
Grossman, Stuart [1 ]
Desideri, Serena [1 ]
Piantadosi, Steven [1 ]
Lesser, Glenn [2 ]
Chamberlain, Marc [3 ]
Ye, Xiaobu [1 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Wake Forest Univ, Winston Salem, NC 27109 USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
NEURO-ONCOLOGY | 2007年 / 9卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：521 / 521
页数：1
相关论文
共 50 条
  • [41] Severe thrombocytopenia from temozolomide (TMZ) in newly diagnosed patients with high-grade gliomas.
    Gerber, David E.
    Grossman, Stuart A.
    CANCER RESEARCH, 2006, 66 (08)
  • [42] Effect of standard therapy on lymphocyte subsets and cytokines in newly diagnosed high-grade gliomas (HGG).
    Balmanoukian, A. S.
    Grossman, S. A.
    Thoburn, C.
    Kos, F.
    Holdhoff, M.
    Hess, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [43] Prognostic value of modified systemic inflammatory score in patients with newly diagnosed high-grade gliomas
    Xie, Tian
    Guo, Xiaoyu
    Duan, Hao
    He, Zhenqiang
    Mou, Yonggao
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2021, 201
  • [44] Concomitant radiochemotherapy with temozolomide in non-selected patients with newly diagnosed high-grade gliomas
    Eberlein, Klaus H.
    Nagel, Britta
    Franz, Kea
    Imhoff, Detlef
    Seifert, Volker
    Boettcher, Heinz D.
    Mose, Stephan
    ANTICANCER RESEARCH, 2006, 26 (6C) : 4959 - 4964
  • [45] Immunosuppression in Patients with High-Grade Gliomas Treated with Radiation and Temozolomide
    Grossman, Stuart A.
    Ye, Xiaobu
    Lesser, Glenn
    Sloan, Andrew
    Carraway, Hetty
    Desideri, Serena
    Piantadosi, Steven
    CLINICAL CANCER RESEARCH, 2011, 17 (16) : 5473 - 5480
  • [46] Temozolomide (TMZ) in radio-chemotherapy combined schedule for treatment of newly-diagnosed high-grade gliomas (HGG).
    Montemaggi, P
    Guerrieri, P
    Mortellaro, G
    Composto, G
    Russo, S
    Piazza, D
    Rizzo, S
    Carreca, I
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 133S - 133S
  • [47] Postoperative concomitant radiochemotherapy in the treatment of primitive cns high-grade gliomas: A retrospective analysis
    Paulo, C.
    Braga, F.
    Sottomayor, C.
    Honavar, M.
    Resende, M.
    Romao, H.
    Teixeira, J.
    NEURO-ONCOLOGY, 2006, 8 (04) : 350 - 350
  • [48] A PILOT STUDY OF BEVACIZUMAB-BASED THERAPY IN CHILDREN AND YOUNG ADULTS WITH NEWLY DIAGNOSED HIGH-GRADE GLIOMAS AND DIFFUSE INTRINSIC PONTINE GLIOMAS
    Dorris, Kathleen
    Wagner, Lars
    Hummel, Trent
    Drissi, Rachid
    Miles, Lili
    Leach, James
    Chow, Lionel
    Turner, Rebecca
    Gragert, Marsha N.
    Pruitt, David
    Sutton, Mary
    Breneman, John
    Crone, Kerry
    Fouladi, Maryam
    NEURO-ONCOLOGY, 2010, 12 : 70 - 70
  • [49] Conventional MRI Criteria to Differentiate Progressive Disease From Treatment-Induced Effects in High-Grade (WHO Grade 3-4) Gliomas
    Flies, Christina M.
    van Leuken, Karlijn H.
    ten Voorde, Marlies
    Verhoeff, Joost J. C.
    De Vos, Filip Y. F.
    Seute, Tatjana
    Robe, Pierre A.
    Witkamp, Theodoor D.
    Hendrikse, Jeroen
    Dankbaar, Jan Willem
    Snijders, Tom J.
    NEUROLOGY, 2022, 99 (01) : E77 - E88
  • [50] Combining Clinical and Molecular Data to Predict the Benefits of Carmustine Wafers in Newly Diagnosed High-Grade Gliomas
    Ius, Tamara
    Cesselli, Daniela
    Isola, Miriam
    Toniato, Giovanni
    Pauletto, Giada
    Sciacca, Giovanni
    Fabbro, Sara
    Pegolo, Enrico
    Rizzato, Simona
    Beltrami, Antonio Paolo
    di Loreto, Carla
    Skrap, Miran
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (02)
12345